Research studies such as the SELECT trial, which used a 2.4 mg weekly dose, do not always specify the brand name, making data attribution to Ozempic or Wegovy sometimes unclear.12 Ozempic and Rybelsus are not currently recommended for pediatric populations
The study is embedded within a broader observational trial that also tracks body composition, physical activity, sleep, diet quality, and cardiometabolic health over time in individuals of all ages initiating HEAOMs.
Interpretation and Clinical Implications These findings demonstrate that semaglutide reduces cardiovascular events independently of baseline adiposity and largely independently of the magnitude of weight loss
Isolating live cell clones from barcoded populations using CRISPRa-inducible reporters
A PARTNER ON YOUR WEIGHT LOSS JOURNEY Medical weight loss is more than just medication
Nat Med 2023;29:150010.ArticlePubMedPDF 38